Loading company…
Oxagen develops biotechnology therapies and diagnostic tools for health conditions.
Founded in 1997, Oxagen is headquartered in Abingdon, UK. Its therapies and diagnostic tools are intended for healthcare providers, patients and research institutions in Europe and North America. In June 2010, it raised GBP 4.5 million in a Series C round led by Wellington Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in